Nanovibronix Stock Market Value
| NAOV Stock | USD 0.44 0.03 6.38% |
| Symbol | NanoVibronix |
NanoVibronix Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoVibronix. If investors know NanoVibronix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoVibronix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.23) | Revenue Per Share | Quarterly Revenue Growth (0.18) | Return On Assets | Return On Equity |
The market value of NanoVibronix is measured differently than its book value, which is the value of NanoVibronix that is recorded on the company's balance sheet. Investors also form their own opinion of NanoVibronix's value that differs from its market value or its book value, called intrinsic value, which is NanoVibronix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoVibronix's market value can be influenced by many factors that don't directly affect NanoVibronix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoVibronix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoVibronix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoVibronix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NanoVibronix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NanoVibronix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NanoVibronix.
| 02/28/2023 |
| 02/17/2025 |
If you would invest 0.00 in NanoVibronix on February 28, 2023 and sell it all today you would earn a total of 0.00 from holding NanoVibronix or generate 0.0% return on investment in NanoVibronix over 720 days. NanoVibronix is related to or competes with Bone Biologics, Bluejay Diagnostics, Vivos Therapeutics, Tivic Health, Heart Test, ReShape Lifesciences, and Nuwellis. NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biolog... More
NanoVibronix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NanoVibronix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NanoVibronix upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 62.96 | |||
| Value At Risk | (9.76) | |||
| Potential Upside | 12.96 |
NanoVibronix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NanoVibronix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NanoVibronix's standard deviation. In reality, there are many statistical measures that can use NanoVibronix historical prices to predict the future NanoVibronix's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (0.16) |
NanoVibronix Backtested Returns
NanoVibronix has Sharpe Ratio of -0.0189, which conveys that the firm had a -0.0189 % return per unit of risk over the last 3 months. NanoVibronix exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NanoVibronix's insignificant Risk Adjusted Performance, mean deviation of 6.03, and Standard Deviation of 9.71 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.18, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, NanoVibronix will likely underperform. At this point, NanoVibronix has a negative expected return of -0.19%. Please make sure to verify NanoVibronix's total risk alpha, kurtosis, as well as the relationship between the Kurtosis and market facilitation index , to decide if NanoVibronix performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.77 |
Good predictability
NanoVibronix has good predictability. Overlapping area represents the amount of predictability between NanoVibronix time series from 28th of February 2023 to 23rd of February 2024 and 23rd of February 2024 to 17th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NanoVibronix price movement. The serial correlation of 0.77 indicates that around 77.0% of current NanoVibronix price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.77 | |
| Spearman Rank Test | 0.71 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
NanoVibronix lagged returns against current returns
Autocorrelation, which is NanoVibronix stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NanoVibronix's stock expected returns. We can calculate the autocorrelation of NanoVibronix returns to help us make a trade decision. For example, suppose you find that NanoVibronix has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NanoVibronix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NanoVibronix stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NanoVibronix stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NanoVibronix stock over time.
Current vs Lagged Prices |
| Timeline |
NanoVibronix Lagged Returns
When evaluating NanoVibronix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NanoVibronix stock have on its future price. NanoVibronix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NanoVibronix autocorrelation shows the relationship between NanoVibronix stock current value and its past values and can show if there is a momentum factor associated with investing in NanoVibronix.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.